Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling. [PDF]
Ribeiro GSG +13 more
europepmc +1 more source
DYRK1A inhibition restores pancreatic functions and improves glucose metabolism in a preclinical model of type 2 diabetes. [PDF]
Bertrand R +10 more
europepmc +1 more source
Harmine promotes axon regeneration through enhancing glucose metabolism. [PDF]
Liu R, Zhou B.
europepmc +1 more source
Probing the Inhibitory Potential of Halogenated Symmetrical Formamidine Against MAO-A and MAO-B: Structural Elucidation, Molecular Dynamic Simulation and DFT Computational Studies. [PDF]
Oladipo SD +6 more
europepmc +1 more source
Unlocking the Power of Plant-Derived Natural Products: Therapeutic Benefits for Cognitive Health and Neuropsychiatric Symptoms in Dementia-Related Diseases. [PDF]
Koyama S +5 more
europepmc +1 more source
Harmine hydrochloride induces G0/G1 cell cycle arrest and apoptosis in oral squamous carcinoma cells. [PDF]
Lin W +5 more
europepmc +1 more source
Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study. [PDF]
Perkins D +9 more
europepmc +1 more source
Investigating the Inhibitory Potential of Halogenated Quinoline Derivatives against MAO‑A and MAO-B: Synthesis, Crystal Structure, Density Functional Theory, and Molecular Dynamics Simulations. [PDF]
Oladipo SD +5 more
europepmc +1 more source
Mechanism of nimodipine in treating neurodegenerative diseases: in silico target identification and molecular dynamic simulation. [PDF]
Zheng S +5 more
europepmc +1 more source
Towards Imaging Tau Hyperphosphorylation: Is DYRK1A a Potential Target for Imaging Hyperphosphorylation of Tau? Molecular Modeling Assessment and Synthesis of [<sup>125</sup>I]Radioiodinated DYRK1A Inhibitor. [PDF]
Paclibar CG +7 more
europepmc +1 more source

